Metabolic
Metabolic
Retatrutide
GIP / GLP-1 / glucagon triple agonist
Retatrutide is a “triple agonist” peptide that engages GIP, GLP-1, and glucagon receptors simultaneously. In current clinical research it has produced some of the largest weight reductions recorded in metabolic trials.
Studied in
Triple-agonist researchWeight managementEnergy balance
$98.00
Ships tracked within 1–3 business days · Certificate of analysis on request · Ask us about this product
Not evaluated by the FDA · Not intended to diagnose, treat, cure, or prevent any disease
Handling. Keep lyophilized vials cool, dry, and away from light. Refrigerate or freeze for long-term storage, and refrigerate after reconstitution. See the storage guide.
